搜尋結果
MDMA-Maker Failed Its FDA Hearing — And Its PTSD Patients
Bloomberg· 18 分鐘前Lykos Therapeutics showed up to a regulatory hearing woefully unprepared. Lisa Jarvis is a ...
Goldman Sachs says buy this biotech stock with more than 60% upside
CNBC· 27 分鐘前It's time for investors to buy the dip on Jazz Pharmaceuticals , according to Goldman ...